Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.
Nipah virus (NiV) disease is a bat-borne zoonosis responsible for outbreaks with high lethality and is a priority for vaccine development. With funding from the Coalition of Epidemic Preparedness Innovations (CEPI), we are developing a chimeric vaccine (PHV02) composed of recombinant vesicular stoma...
Main Authors: | Thomas P Monath, Richard Nichols, Lynda Tussey, Kelly Scappaticci, Thaddeus G Pullano, Mary D Whiteman, Nikos Vasilakis, Shannan L Rossi, Rafael Kroon Campos, Sasha R Azar, Heidi M Spratt, Brent L Seaton, W Tad Archambault, Yanina V Costecalde, Evan H Moore, Roger J Hawks, Joan Fusco |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-06-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1010658 |
Similar Items
-
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease
by: Thomas P. Monath, et al.
Published: (2023-09-01) -
Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease
by: Courtney Woolsey, et al.
Published: (2023-02-01) -
Enterovirus vesicular stomatitis with exanthema: Epidemiological Features and Vaccination
by: Yu. S. Sytaya, et al.
Published: (2022-07-01) -
Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species
by: Nicholas A. Bergren, et al.
Published: (2018-04-01) -
Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
by: Guodong Liu, et al.
Published: (2021-08-01)